The global market for Tuberculosis Prevention and Treatment Vaccine was estimated to be worth US$ 74 million in 2023 and is forecast to a readjusted size of US$ 102 million by 2030 with a CAGR of 4.6% during the forecast period 2024-2030

Tuberculosis Prevention and Treatment Vaccine - Market

Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.

Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tuberculosis Prevention and Treatment Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Tuberculosis Prevention and Treatment Vaccine by region & country, by Type, and by Application.

The Tuberculosis Prevention and Treatment Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Prevention and Treatment Vaccine.

Market Segmentation

Scope of Tuberculosis Prevention and Treatment Vaccine - Market Report

Report Metric	Details
Report Name	Tuberculosis Prevention and Treatment Vaccine - Market
Forecasted market size in 2030	US$ 102 million
CAGR	4.6%
Forecasted years	2024 - 2030
Segment by Type:	Immune Vaccine Therapy Vaccine
Segment by Application	Self-Procurement UNICEF Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, IVAC, Queen Saovabha Mem. Inst, Microgen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Tuberculosis Prevention and Treatment Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Tuberculosis Prevention and Treatment Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Tuberculosis Prevention and Treatment Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Tuberculosis Prevention and Treatment Vaccine - Market size in 2030?

Ans: The Tuberculosis Prevention and Treatment Vaccine - Market size in 2030 will be US$ 102 million.

Who are the main players in the Tuberculosis Prevention and Treatment Vaccine - Market report?

Ans: The main players in the Tuberculosis Prevention and Treatment Vaccine - Market are Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin, Taj Pharmaceuticals, Ataulpho de Paiva, IVAC, Queen Saovabha Mem. Inst, Microgen

What are the Application segmentation covered in the Tuberculosis Prevention and Treatment Vaccine - Market report?

Ans: The Applications covered in the Tuberculosis Prevention and Treatment Vaccine - Market report are Self-Procurement, UNICEF, Other

What are the Type segmentation covered in the Tuberculosis Prevention and Treatment Vaccine - Market report?

Ans: The Types covered in the Tuberculosis Prevention and Treatment Vaccine - Market report are Immune Vaccine, Therapy Vaccine

1 Market Overview

1.1 Tuberculosis Prevention and Treatment Vaccine Product Introduction

1.2 Global Tuberculosis Prevention and Treatment Vaccine Market Size Forecast

1.2.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Value (2019-2030)

1.2.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Volume (2019-2030)

1.2.3 Global Tuberculosis Prevention and Treatment Vaccine Sales Price (2019-2030)

1.3 Tuberculosis Prevention and Treatment Vaccine Market Trends & Drivers

1.3.1 Tuberculosis Prevention and Treatment Vaccine Industry Trends

1.3.2 Tuberculosis Prevention and Treatment Vaccine Market Drivers & Opportunity

1.3.3 Tuberculosis Prevention and Treatment Vaccine Market Challenges

1.3.4 Tuberculosis Prevention and Treatment Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Tuberculosis Prevention and Treatment Vaccine Players Revenue Ranking (2023)

2.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Company (2019-2024)

2.3 Global Tuberculosis Prevention and Treatment Vaccine Players Sales Volume Ranking (2023)

2.4 Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Tuberculosis Prevention and Treatment Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Tuberculosis Prevention and Treatment Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Tuberculosis Prevention and Treatment Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Tuberculosis Prevention and Treatment Vaccine

2.9 Tuberculosis Prevention and Treatment Vaccine Market Competitive Analysis

2.9.1 Tuberculosis Prevention and Treatment Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Tuberculosis Prevention and Treatment Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Prevention and Treatment Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Immune Vaccine

3.1.2 Therapy Vaccine

3.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Type

3.2.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Tuberculosis Prevention and Treatment Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Type

3.3.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Tuberculosis Prevention and Treatment Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Tuberculosis Prevention and Treatment Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Self-Procurement

4.1.2 UNICEF

4.1.3 Other

4.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Application

4.2.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Tuberculosis Prevention and Treatment Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Application

4.3.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Tuberculosis Prevention and Treatment Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Tuberculosis Prevention and Treatment Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Region

5.1.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Region

5.2.1 Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Tuberculosis Prevention and Treatment Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Tuberculosis Prevention and Treatment Vaccine Sales Value, 2019-2030

5.4.2 North America Tuberculosis Prevention and Treatment Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Tuberculosis Prevention and Treatment Vaccine Sales Value, 2019-2030

5.5.2 Europe Tuberculosis Prevention and Treatment Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Tuberculosis Prevention and Treatment Vaccine Sales Value, 2019-2030

5.7.2 South America Tuberculosis Prevention and Treatment Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Tuberculosis Prevention and Treatment Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Tuberculosis Prevention and Treatment Vaccine Sales Value

6.2.1 Key Countries/Regions Tuberculosis Prevention and Treatment Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Tuberculosis Prevention and Treatment Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Tuberculosis Prevention and Treatment Vaccine Sales Value, 2019-2030

6.3.2 United States Tuberculosis Prevention and Treatment Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Tuberculosis Prevention and Treatment Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Tuberculosis Prevention and Treatment Vaccine Sales Value, 2019-2030

6.4.2 Europe Tuberculosis Prevention and Treatment Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Tuberculosis Prevention and Treatment Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Tuberculosis Prevention and Treatment Vaccine Sales Value, 2019-2030

6.5.2 China Tuberculosis Prevention and Treatment Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Tuberculosis Prevention and Treatment Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Tuberculosis Prevention and Treatment Vaccine Sales Value, 2019-2030

6.6.2 Japan Tuberculosis Prevention and Treatment Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Tuberculosis Prevention and Treatment Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Tuberculosis Prevention and Treatment Vaccine Sales Value, 2019-2030

6.7.2 South Korea Tuberculosis Prevention and Treatment Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Tuberculosis Prevention and Treatment Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Tuberculosis Prevention and Treatment Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Tuberculosis Prevention and Treatment Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Tuberculosis Prevention and Treatment Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Tuberculosis Prevention and Treatment Vaccine Sales Value, 2019-2030

6.9.2 India Tuberculosis Prevention and Treatment Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Tuberculosis Prevention and Treatment Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Merck

7.1.1 Merck Company Information

7.1.2 Merck Introduction and Business Overview

7.1.3 Merck Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Merck Tuberculosis Prevention and Treatment Vaccine Product Offerings

7.1.5 Merck Recent Development

7.2 Japan BCG Lab

7.2.1 Japan BCG Lab Company Information

7.2.2 Japan BCG Lab Introduction and Business Overview

7.2.3 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Offerings

7.2.5 Japan BCG Lab Recent Development

7.3 Serum Institute of India

7.3.1 Serum Institute of India Company Information

7.3.2 Serum Institute of India Introduction and Business Overview

7.3.3 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Offerings

7.3.5 Serum Institute of India Recent Development

7.4 AJ Vaccines

7.4.1 AJ Vaccines Company Information

7.4.2 AJ Vaccines Introduction and Business Overview

7.4.3 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Offerings

7.4.5 AJ Vaccines Recent Development

7.5 BioFarma

7.5.1 BioFarma Company Information

7.5.2 BioFarma Introduction and Business Overview

7.5.3 BioFarma Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 BioFarma Tuberculosis Prevention and Treatment Vaccine Product Offerings

7.5.5 BioFarma Recent Development

7.6 GreenSignal Bio Pharma

7.6.1 GreenSignal Bio Pharma Company Information

7.6.2 GreenSignal Bio Pharma Introduction and Business Overview

7.6.3 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Offerings

7.6.5 GreenSignal Bio Pharma Recent Development

7.7 China National Biotec

7.7.1 China National Biotec Company Information

7.7.2 China National Biotec Introduction and Business Overview

7.7.3 China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Offerings

7.7.5 China National Biotec Recent Development

7.8 Biomed Lublin

7.8.1 Biomed Lublin Company Information

7.8.2 Biomed Lublin Introduction and Business Overview

7.8.3 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Offerings

7.8.5 Biomed Lublin Recent Development

7.9 Taj Pharmaceuticals

7.9.1 Taj Pharmaceuticals Company Information

7.9.2 Taj Pharmaceuticals Introduction and Business Overview

7.9.3 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Offerings

7.9.5 Taj Pharmaceuticals Recent Development

7.10 Ataulpho de Paiva

7.10.1 Ataulpho de Paiva Company Information

7.10.2 Ataulpho de Paiva Introduction and Business Overview

7.10.3 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Offerings

7.10.5 Ataulpho de Paiva Recent Development

7.11 IVAC

7.11.1 IVAC Company Information

7.11.2 IVAC Introduction and Business Overview

7.11.3 IVAC Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.11.4 IVAC Tuberculosis Prevention and Treatment Vaccine Product Offerings

7.11.5 IVAC Recent Development

7.12 Queen Saovabha Mem. Inst

7.12.1 Queen Saovabha Mem. Inst Company Information

7.12.2 Queen Saovabha Mem. Inst Introduction and Business Overview

7.12.3 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Offerings

7.12.5 Queen Saovabha Mem. Inst Recent Development

7.13 Microgen

7.13.1 Microgen Company Information

7.13.2 Microgen Introduction and Business Overview

7.13.3 Microgen Tuberculosis Prevention and Treatment Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Microgen Tuberculosis Prevention and Treatment Vaccine Product Offerings

7.13.5 Microgen Recent Development

8 Industry Chain Analysis

8.1 Tuberculosis Prevention and Treatment Vaccine Industrial Chain

8.2 Tuberculosis Prevention and Treatment Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Tuberculosis Prevention and Treatment Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Tuberculosis Prevention and Treatment Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Merck

Japan BCG Lab

Serum Institute of India

AJ Vaccines

Biofarma

GreenSignal Bio Pharma

China National Biotec

Queen Saovabha Mem. Inst

Microgen

List of Tables

Table 1. Tuberculosis Prevention and Treatment Vaccine Market Trends

Table 2. Tuberculosis Prevention and Treatment Vaccine Market Drivers & Opportunity

Table 3. Tuberculosis Prevention and Treatment Vaccine Market Challenges

Table 4. Tuberculosis Prevention and Treatment Vaccine Market Restraints

Table 5. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Tuberculosis Prevention and Treatment Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Tuberculosis Prevention and Treatment Vaccine Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Tuberculosis Prevention and Treatment Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Tuberculosis Prevention and Treatment Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Tuberculosis Prevention and Treatment Vaccine

Table 13. Global Tuberculosis Prevention and Treatment Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Prevention and Treatment Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Tuberculosis Prevention and Treatment Vaccine Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Tuberculosis Prevention and Treatment Vaccine Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Tuberculosis Prevention and Treatment Vaccine Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Tuberculosis Prevention and Treatment Vaccine Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Tuberculosis Prevention and Treatment Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Tuberculosis Prevention and Treatment Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Tuberculosis Prevention and Treatment Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Tuberculosis Prevention and Treatment Vaccine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Tuberculosis Prevention and Treatment Vaccine Sales Volume, (2025-2030) & (K Units)

Table 57. Merck Company Information

Table 58. Merck Introduction and Business Overview

Table 59. Merck Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Merck Tuberculosis Prevention and Treatment Vaccine Product Offerings

Table 61. Merck Recent Development

Table 62. Japan BCG Lab Company Information

Table 63. Japan BCG Lab Introduction and Business Overview

Table 64. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product Offerings

Table 66. Japan BCG Lab Recent Development

Table 67. Serum Institute of India Company Information

Table 68. Serum Institute of India Introduction and Business Overview

Table 69. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product Offerings

Table 71. Serum Institute of India Recent Development

Table 72. AJ Vaccines Company Information

Table 73. AJ Vaccines Introduction and Business Overview

Table 74. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product Offerings

Table 76. AJ Vaccines Recent Development

Table 77. BioFarma Company Information

Table 78. BioFarma Introduction and Business Overview

Table 79. BioFarma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. BioFarma Tuberculosis Prevention and Treatment Vaccine Product Offerings

Table 81. BioFarma Recent Development

Table 82. GreenSignal Bio Pharma Company Information

Table 83. GreenSignal Bio Pharma Introduction and Business Overview

Table 84. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product Offerings

Table 86. GreenSignal Bio Pharma Recent Development

Table 87. China National Biotec Company Information

Table 88. China National Biotec Introduction and Business Overview

Table 89. China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. China National Biotec Tuberculosis Prevention and Treatment Vaccine Product Offerings

Table 91. China National Biotec Recent Development

Table 92. Biomed Lublin Company Information

Table 93. Biomed Lublin Introduction and Business Overview

Table 94. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product Offerings

Table 96. Biomed Lublin Recent Development

Table 97. Taj Pharmaceuticals Company Information

Table 98. Taj Pharmaceuticals Introduction and Business Overview

Table 99. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product Offerings

Table 101. Taj Pharmaceuticals Recent Development

Table 102. Ataulpho de Paiva Company Information

Table 103. Ataulpho de Paiva Introduction and Business Overview

Table 104. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product Offerings

Table 106. Ataulpho de Paiva Recent Development

Table 107. IVAC Company Information

Table 108. IVAC Introduction and Business Overview

Table 109. IVAC Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. IVAC Tuberculosis Prevention and Treatment Vaccine Product Offerings

Table 111. IVAC Recent Development

Table 112. Queen Saovabha Mem. Inst Company Information

Table 113. Queen Saovabha Mem. Inst Introduction and Business Overview

Table 114. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product Offerings

Table 116. Queen Saovabha Mem. Inst Recent Development

Table 117. Microgen Company Information

Table 118. Microgen Introduction and Business Overview

Table 119. Microgen Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Microgen Tuberculosis Prevention and Treatment Vaccine Product Offerings

Table 121. Microgen Recent Development

Table 122. Key Raw Materials Lists

Table 123. Raw Materials Key Suppliers Lists

Table 124. Tuberculosis Prevention and Treatment Vaccine Downstream Customers

Table 125. Tuberculosis Prevention and Treatment Vaccine Distributors List

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Tuberculosis Prevention and Treatment Vaccine Product Picture

Figure 2. Global Tuberculosis Prevention and Treatment Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Tuberculosis Prevention and Treatment Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Tuberculosis Prevention and Treatment Vaccine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Tuberculosis Prevention and Treatment Vaccine Sales Price (2019-2030) & (US$/Unit)

Figure 6. Tuberculosis Prevention and Treatment Vaccine Report Years Considered

Figure 7. Global Tuberculosis Prevention and Treatment Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Tuberculosis Prevention and Treatment Vaccine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Tuberculosis Prevention and Treatment Vaccine Revenue in 2023

Figure 10. Tuberculosis Prevention and Treatment Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Immune Vaccine Picture

Figure 12. Therapy Vaccine Picture

Figure 13. Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Tuberculosis Prevention and Treatment Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Tuberculosis Prevention and Treatment Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Self-Procurement

Figure 19. Product Picture of UNICEF

Figure 20. Product Picture of Other

Figure 21. Global Tuberculosis Prevention and Treatment Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Tuberculosis Prevention and Treatment Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Tuberculosis Prevention and Treatment Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Tuberculosis Prevention and Treatment Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Tuberculosis Prevention and Treatment Vaccine Price by Application (2019-2030) & (US$/Unit)

Figure 26. North America Tuberculosis Prevention and Treatment Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Tuberculosis Prevention and Treatment Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Tuberculosis Prevention and Treatment Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Tuberculosis Prevention and Treatment Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Tuberculosis Prevention and Treatment Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Tuberculosis Prevention and Treatment Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Tuberculosis Prevention and Treatment Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Tuberculosis Prevention and Treatment Vaccine Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Tuberculosis Prevention and Treatment Vaccine Sales Volume (%), (2019-2030)

Figure 38. United States Tuberculosis Prevention and Treatment Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Tuberculosis Prevention and Treatment Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Tuberculosis Prevention and Treatment Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Tuberculosis Prevention and Treatment Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Tuberculosis Prevention and Treatment Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Tuberculosis Prevention and Treatment Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 44. China Tuberculosis Prevention and Treatment Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Tuberculosis Prevention and Treatment Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 46. China Tuberculosis Prevention and Treatment Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Tuberculosis Prevention and Treatment Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Tuberculosis Prevention and Treatment Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Tuberculosis Prevention and Treatment Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Tuberculosis Prevention and Treatment Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Tuberculosis Prevention and Treatment Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Tuberculosis Prevention and Treatment Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Tuberculosis Prevention and Treatment Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Tuberculosis Prevention and Treatment Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Tuberculosis Prevention and Treatment Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 56. India Tuberculosis Prevention and Treatment Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Tuberculosis Prevention and Treatment Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 58. India Tuberculosis Prevention and Treatment Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 59. Tuberculosis Prevention and Treatment Vaccine Industrial Chain

Figure 60. Tuberculosis Prevention and Treatment Vaccine Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions